| Pfizer asks EU to approve kidney cancer drug - BusinessWeek |
|
|
BusinessWeek Pfizer wants approval to market axitinib as a treatment for advanced renal cell carcinoma in patients who haven't been helped by other therapies. Axitinib is taken by mouth and is designed to block receptors that influence tumor growth, blood vessel ... Pfizer Files For European Regulatory Review Of Axitinib For Patients With |